| RS2116382630 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS2116383424 |
CLCN1
|
Health Risk |
Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116384132 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116384200 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS2116384455 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116384695 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116384782 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116397821 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal dominant form |
| RS2116397860 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS2116402799 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS2116403812 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116406254 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS2116407521 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116407816 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116411134 |
TRRAP
|
Health Risk |
Likely pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS2116412345 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
SAMD9-related disorder, SAMD9-related disorder |
| RS2116413904 |
EPHB4
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116413948 |
EPHB4
|
Health Risk |
Pathogenic |
Arteriovenous malformation, Arteriovenous malformation |
| RS2116414460 |
EPHB4
|
Health Risk |
Likely pathogenic |
— |
| RS2116414744 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116415082 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116415261 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116415268 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116415497 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2116416678 |
EPHB4
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116417034 |
SAMD9
|
Health Risk |
Likely pathogenic |
— |
| RS2116417794 |
SAMD9
|
Health Risk |
Likely pathogenic |
— |
| RS2116418899 |
SAMD9
|
Health Risk |
Likely pathogenic |
— |
| RS2116420330 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116421906 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116422065 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116426311 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS2116431583 |
EPHB4
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116431707 |
EPHB4
|
Health Risk |
Pathogenic |
Hereditary lymphedema type I, Hereditary lymphedema type I |
| RS2116431816 |
EPHB4
|
Health Risk |
Pathogenic |
— |
| RS2116432544 |
EPHB4
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116432568 |
EPHB4
|
Health Risk |
Likely pathogenic |
— |
| RS2116434296 |
EPHB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, Lymphatic malformation 7 |
| RS2116434413 |
EPHB4
|
Health Risk |
Likely pathogenic |
— |
| RS2116435260 |
EPHB4
|
Health Risk |
Pathogenic/Likely pathogenic |
EPHB4-related disorder, EPHB4-related disorder |
| RS2116435454 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116438660 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116443777 |
EPHB4
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116443784 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116443901 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116444559 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116444583 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116449991 |
EPHB4
|
Health Risk |
association |
Vein of Galen aneurysmal malformation, Vein of Galen aneurysmal malformation |
| RS2116450530 |
EPHB4
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116451858 |
EPHB4
|
Health Risk |
Pathogenic |
— |
| RS2116458223 |
EPHB4
|
Health Risk |
Pathogenic |
— |
| RS2116460981 |
POT1
|
Health Risk |
Likely pathogenic |
— |
| RS2116461581 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116461878 |
EPHB4
|
Health Risk |
Pathogenic |
EPHB4-related disorder, EPHB4-related disorder |
| RS2116461987 |
EPHB4
|
Health Risk |
Pathogenic |
— |
| RS2116462820 |
EPHB4
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2116463248 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS2116467712 |
SAMD9L
|
Health Risk |
Likely pathogenic |
Monosomy 7 myelodysplasia and leukemia syndrome 1, Monosomy 7 myelodysplasia and leukemia syndrome 1 |
| RS2116469012 |
SAMD9L
|
Health Risk |
Pathogenic |
— |
| RS2116474071 |
EPHB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation 2, Capillary malformation-arteriovenous malformation 2 |
| RS2116481274 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116482158 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS2116485921 |
SAMD9L
|
Health Risk |
Likely pathogenic |
— |
| RS2116486108 |
SAMD9L
|
Health Risk |
Likely pathogenic |
interferonopathy, interferonopathy |
| RS2116495090 |
TRRAP
|
Health Risk |
Likely pathogenic |
— |
| RS2116495128 |
TRRAP
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2116495143 |
TRRAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS2116495297 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2116500720 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116500730 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116501128 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116504255 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116504536 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116504827 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Long telomere syndrome |
| RS2116504894 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116505095 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116505279 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116505365 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116505374 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116505401 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116506727 |
SAMD9L
|
Health Risk |
Likely pathogenic |
Monosomy 7 myelodysplasia and leukemia syndrome 1, Monosomy 7 myelodysplasia and leukemia syndrome 1 |
| RS2116509058 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2116509105 |
TRRAP
|
Health Risk |
Likely pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS2116512210 |
TRRAP
|
Health Risk |
Likely pathogenic |
Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without dysmorphic facies and autism |
| RS2116525031 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116525148 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tumor predisposition syndrome 3 |
| RS2116525878 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116526207 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116526253 |
POT1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2116526346 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116526564 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116541623 |
POT1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2116542157 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Long telomere syndrome |
| RS2116542410 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116542675 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS2116567355 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS2116567603 |
POT1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2116568066 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS2116574924 |
POU6F2
|
Health Risk |
Pathogenic |
Wilms tumor 5, Wilms tumor 5 |
| RS2116581086 |
GIMAP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Portal hypertension, noncirrhotic |